Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FENNEC PHARMACEUTICALS INC.

(FENC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/21/2021 09/22/2021 09/23/2021 09/24/2021 09/27/2021 Date
8.61(c) 8.73(c) 9.4(c) 9.39(c) 9.35 Last
37 817 25 692 94 825 50 583 33 165 Volume
+1.29% +1.39% +7.67% -0.11% -0.43% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 21,0 M - -
Net income 2021 -17,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 -14,2x
Yield 2021 -
Sales 2022 20,1 M - -
Net income 2022 -3,64 M - -
Net Debt 2022 - - -
P/E ratio 2022 -73,4x
Yield 2022 -
Capitalization 244 M 244 M -
Capi. / Sales 2021 11,6x
Capi. / Sales 2022 12,2x
Nbr of Employees 9
Free-Float 83,1%
More Financials
Company
Fennec Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development of PEDMARK for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The CompanyÔÇÖs only product candidate in the clinical stage of development is PEDMARK. It announced two results of Phase III clinical trials for the prevention of cisplatin induced hearing loss, or ototoxicity in children,... 
Sector
Biotechnology & Medical Research
Calendar
09/29 | 10:40amPresentation
More about the company
Ratings of Fennec Pharmaceuticals Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about FENNEC PHARMACEUTICALS INC.
09/09FENNEC PHARMACEUTICALS : to Participate in Upcoming Investor Conferences
AQ
08/10FENNEC PHARMACEUTICALS : Wedbush Lifts Price Target for Fennec Pharmaceuticals to $12 From..
MT
08/10FENNEC PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R..
AQ
08/10FENNEC PHARMACEUTICALS : Reports Q2 Net loss of US$0.15 Per Share; Provides Business Updat..
MT
08/10FENNEC PHARMACEUTICALS : Earnings Flash (FRX.TO) FENNEC PHARMACEUTICALS Posts Net loss for..
MT
08/10FENNEC PHARMACEUTICALS : Earnings Flash (FRX.TO) FENNEC PHARMACEUTICALS Posts Net loss for..
MT
08/10Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Bus..
GL
08/06NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
DJ
06/30FENNEC PHARMACEUTICALS INC. : Submission of Matters to a Vote of Security Holders (form 8-..
AQ
06/29Fennec Announces Results of Annual Meeting
GL
06/25FENNEC PHARMACEUTICALS : ANNOUNCES AMENDMENT TO INCREASE EXISTING SENIOR DEBT FACILITY (Fo..
PU
06/25FENNEC PHARMACEUTICALS INC.(NASDAQCM : FENC) dropped from Russell 3000E Index
CI
06/25FENNEC PHARMACEUTICALS INC.(NASDAQCM : FENC) dropped from Russell 2500 Growth Index
CI
06/25FENNEC PHARMACEUTICALS INC.(NASDAQCM : FENC) dropped from Russell 2500 Index
CI
06/25FENNEC PHARMACEUTICALS INC.(NASDAQCM : FENC) dropped from Russell 2000 Growth Index
CI
More news
News in other languages on FENNEC PHARMACEUTICALS INC.

- No features available -

More news
Analyst Recommendations on FENNEC PHARMACEUTICALS INC.
More recommendations
Chart FENNEC PHARMACEUTICALS INC.
Duration : Period :
Fennec Pharmaceuticals Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FENNEC PHARMACEUTICALS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 9,39 $
Average target price 13,60 $
Spread / Average Target 44,8%
EPS Revisions
Managers and Directors
Rostislav C. Raykov Chief Executive Officer & Director
Robert C. Andrade Chief Financial Officer
Khalid Islam Chairman
Chris A. Rallis Independent Director
Adrian James Haigh Independent Director
Sector and Competitors
1st jan.Capi. (M$)
FENNEC PHARMACEUTICALS INC.26.04%244
GILEAD SCIENCES, INC.22.19%89 259
BIONTECH SE309.08%80 542
REGENERON PHARMACEUTICALS32.25%66 425
WUXI APPTEC CO., LTD.34.39%59 817
VERTEX PHARMACEUTICALS-22.31%47 634